Metabolomic Assessment of Embryo Viability

dc.authoridUyar, Asli/0000-0002-7913-1083
dc.authorscopusid55664907400
dc.authorscopusid6701473546
dc.contributor.authorUyar, Asli
dc.contributor.authorSeli, Emre
dc.contributor.otherBilgisayar Mühendisliği / Computer Engineering
dc.date.accessioned2024-05-25T11:24:07Z
dc.date.available2024-05-25T11:24:07Z
dc.date.issued2014
dc.departmentOkan Universityen_US
dc.department-temp[Uyar, Asli; Seli, Emre] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Uyar, Asli] Okan Univ, Dept Comp Engn, Istanbul, Turkeyen_US
dc.descriptionUyar, Asli/0000-0002-7913-1083en_US
dc.description.abstractPreimplantation embryo metabolism demonstrates distinctive characteristics associated with the developmental potential of embryos. On this basis, metabolite content of culture media was hypothesized to reflect the implantation potential of individual embryos. This hypothesis was tested in consecutive studies reporting a significant association between culture media metabolites and embryo development or clinical pregnancy. The need for a noninvasive, reliable, and rapid embryo assessment strategy promoted metabolomics studies in vitro fertilization (IVF) in an effort to increase success rates of single embryo transfers. With the advance of analytical techniques and bioinformatics, commercial instruments were developed to predict embryo viability using spectroscopic analysis of surplus culture media. However, despite the initial promising results from proof-of-principal studies, recent randomized controlled trials using commercial instruments failed to show a consistent benefit in improving pregnancy rates when metabolomics is used as an adjunct to morphology. At present, the application of metabolomics technology in clinical IVF laboratory requires the elimination of factors underlying inconsistent findings, when possible, and development of reliable predictive models accounting for all possible sources of bias throughout the embryo selection process.en_US
dc.description.sponsorshipNational Institutes of Health (NIH) [R01HD059909]en_US
dc.description.sponsorshipE.S. is supported by award no. R01HD059909 from the National Institutes of Health (NIH).en_US
dc.identifier.citation48
dc.identifier.doi10.1055/s-0033-1363556
dc.identifier.endpage151en_US
dc.identifier.issn1526-8004
dc.identifier.issn1526-4564
dc.identifier.issue2en_US
dc.identifier.pmid24515909
dc.identifier.scopus2-s2.0-84907623415
dc.identifier.scopusqualityQ2
dc.identifier.startpage141en_US
dc.identifier.urihttps://doi.org/10.1055/s-0033-1363556
dc.identifier.urihttps://hdl.handle.net/20.500.14517/759
dc.identifier.volume32en_US
dc.identifier.wosWOS:000331288800010
dc.identifier.wosqualityQ2
dc.institutionauthorUyar A.
dc.institutionauthorUyar, Aslı
dc.language.isoen
dc.publisherThieme Medical Publ incen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectembryo assessmenten_US
dc.subjectmetabolomicsen_US
dc.titleMetabolomic Assessment of Embryo Viabilityen_US
dc.typeArticleen_US
dspace.entity.typePublication
relation.isAuthorOfPublication9cfff5a5-9c60-4015-8119-1add2ac5a936
relation.isAuthorOfPublication.latestForDiscovery9cfff5a5-9c60-4015-8119-1add2ac5a936
relation.isOrgUnitOfPublicationc8741b9b-4455-4984-a245-360ece4aa1d9
relation.isOrgUnitOfPublication.latestForDiscoveryc8741b9b-4455-4984-a245-360ece4aa1d9

Files